Medical Weight Loss
in the West Loop.
Semaglutide and Tirzepatide at TRIA, 1101 W Monroe. Stubborn weight is rarely a failure of willpower — it is often a metabolic and hormonal problem. GLP-1 therapy here is clinician-supervised, personalised, and built around your biology.
It's Not Willpower.
It's Metabolic Resistance.
When you restrict calories, your body activates survival mechanisms — slowing metabolism and defending fat stores. GLP-1 medications bypass this resistance.
Protocol Efficacy
Average total body weight reduction across 12 months. GLP-1 therapy shows statistically significant superiority over traditional behavioral interventions alone.
Metabolic rate slows with caloric restriction
Hunger hormones (ghrelin) increase after weight loss
Fat cells actively resist being emptied
Insulin resistance blocks fat metabolism
Hormonal imbalances amplify all of the above
Semaglutide vs. Tirzepatide
Both are clinically proven. The right choice depends on your biology, medical history, and treatment goals. Our clinicians determine the optimal protocol during your initial consultation.
Semaglutide
Ozempic / Wegovy
The original and most studied GLP-1 medication. Weekly injection that reduces appetite, regulates insulin, and slows gastric emptying. Clinical trials show average weight loss of 14.9% over 68 weeks.
First-line GLP-1 therapy, cardiovascular risk patients
Tirzepatide
Mounjaro / Zepbound
A newer dual-agonist that targets both GLP-1 and GIP receptors simultaneously — producing more significant weight loss than semaglutide alone for many patients. Clinical trials show average loss of 20–22% body weight.
Patients seeking maximum efficacy, or those with inadequate response to semaglutide
Medical disclaimer: GLP-1 medications require a clinical consultation and prescription. Eligibility criteria apply (BMI ≥30, or ≥27 with weight-related comorbidities). All treatments at TRIA are physician-supervised.
Six Reasons GLP-1 Works
Clinically Significant Weight Loss
Clinical trials demonstrate up to 15–20% total body weight reduction with GLP-1 therapy. This exceeds what is achievable through diet and exercise alone for most patients with metabolic resistance.
Metabolic Recalibration
GLP-1 agonists improve insulin sensitivity, regulate blood glucose, and positively affect lipid profiles — addressing the underlying metabolic dysfunction that makes weight loss so difficult.
Appetite & Craving Reduction
By signalling satiety to the brain and slowing gastric emptying, GLP-1 medications reduce hunger and food cravings at a neurological level — not through willpower alone.
Sustainable Long-Term Results
Unlike crash diets, medically supervised GLP-1 therapy supports weight maintenance over time by retraining the body's set-point and metabolic response to food.
Cardiovascular Protection
Studies demonstrate reduced risk of major cardiovascular events — heart attack and stroke — in patients using GLP-1 therapy, making it beneficial well beyond weight management.
Comprehensive Clinical Support
At TRIA, GLP-1 therapy is prescribed as part of a full protocol — including nutritional guidance, activity recommendations, and regular provider check-ins to adjust dosing as you progress.
What to Expect
Consultation
Comprehensive assessment of your health history, metabolic markers, and weight loss goals. We identify the right protocol for your biology.
Bloodwork
Baseline labs to check hormones, thyroid, glucose, and lipid panels. This guides medication selection and starting dose.
Protocol Start
Begin with a low dose, titrated gradually to minimise side effects. Weekly injection, administered at home or in-office.
Ongoing Care
Regular check-ins to review progress, adjust dosing, and provide nutritional and lifestyle guidance throughout your journey.
Is an Imbalance Slowing Your Progress?
Weight resistance is often linked to underlying hormonal decline.
The GLP-1 Patient Guide
Clinical data on Semaglutide and Tirzepatide for metabolic recalibration.
Meet Your Clinician
Violet Magiera DNP, APRN-FPA, FNP-C
Violet brings a Doctorate in Nursing Practice and extensive clinical experience to TRIA's metabolic wellness programs. She specializes in the intersection of endocrine health and weight management, ensuring your weight loss journey is medically optimized and sustainable.
@np_violetServing West Loop, River North & Greater Chicago
TRIA is located at 1101 W Monroe St in Chicago's West Loop — a short ride from River North, Fulton Market, the Loop, and Greektown, with easy access from the Morgan and Racine CTA stops. Patients typically come to us for Semaglutide or Tirzepatide when they want clinician-supervised dosing, labs, and a plan that also looks at hormones — not a five-minute online intake.
GLP-1 protocols pair naturally with our hormone optimization (BHRT) and peptide therapy programs when metabolic and endocrine issues overlap.
West Loop professionals who have plateaued on diet and training alone
Patients comparing Semaglutide vs Tirzepatide and want a clinical recommendation
People who need in-person follow-up rather than mail-order GLP-1
Patients whose weight resistance may be tied to hormone decline
Anyone searching for medical weight loss near River North or Fulton Market
Ready to Start?
A consultation with our clinical team takes 45 minutes. We review your history, order labs if needed, and build a personalised weight loss protocol — all in one visit.
Book Your Consultation